Concepedia

Fengbin Jin

FJ

Statistics

Publications

5

Citations

197

H-Index

5

Active since

2015

Affiliations

Sunovion (United States)(Current)

Vion Pharmaceuticals (United States)

PTC Therapeutics (United States)

Fengbin Jin is an author at Sunovion (United States) specializing in atherosclerosis, pharmacokinetic modeling, and clinical pharmacology.

Top concepts

Publications per year

2015–2019

5

Publications

5

Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults

Kenneth S. Koblan, Seth C. Hopkins, Kaushik Sarma et al. · Neuropsychopharmacology · 2015 · 63 citations · Full text

Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial

Perry B. Shieh, Joseph McIntosh, Fengbin Jin et al. · Muscle & Nerve · 2018 · 59 citations · Full text

Pharmacokinetics and Tolerability of Lurasidone in Children and Adolescents With Psychiatric Disorders

Robert L. Findling, Robert Goldman, Yu-Yuan Chiu et al. · Clinical Therapeutics · 2015 · 49 citations · Full text

Assessment of human abuse potential of dasotraline compared to methylphenidate and placebo in recreational stimulant users

Kenneth S. Koblan, Seth C. Hopkins, Kaushik Sarma et al. · Drug and Alcohol Dependence · 2015 · 16 citations · Full text

Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects

Ronald Kong, Oscar L. Laskin, Diksha Kaushik et al. · Clinical Pharmacology in Drug Development · 2019 · 10 citations · Full text

, , +16

1–5 of 5